Royal Bank Of Canada Molecular Templates, Inc. Transaction History

Royal Bank Of Canada

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.39 - $0.54 $205 - $284	527 Added 163.16%	850 $0
Q4 2022 Feb 14, 2023	SELL	$0.33 - $12.0 $17 - $636	-53 Reduced 14.1%	323 $0
Q3 2022 Nov 14, 2022	BUY	$0.68 - $11.25 $41 - $686	61 Added 19.37%	376 $0
Q2 2022 Aug 15, 2022	SELL	$0.81 - $3.43 $1,585 - $6,712	-1,957 Reduced 86.14%	315 $0
Q1 2022 May 16, 2022	SELL	$2.27 - $4.13 $13,590 - $24,726	-5,987 Reduced 72.49%	2,272 $8,000
Q4 2021 Feb 14, 2022	BUY	$3.37 - $6.87 $10,356 - $21,111	3,073 Added 59.26%	8,259 $32,000
Q3 2021 Nov 15, 2021	BUY	$5.78 - $7.86 $14,814 - $20,145	2,563 Added 97.71%	5,186 $35,000
Q2 2021 Aug 16, 2021	BUY	$7.82 - $12.44 $20,511 - $32,630	2,623 New	2,623 $21,000

499K

Ticker MTEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,351,600
Description
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developi...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.